Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.82% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.26% |
| 4 | Consumer Discretionary | 1.92% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
CALL
Lennar Class A
LEN
$20.5B
| $41.2M | 0.01% |
603,065
+105,056
| +21% | +$7.7M |
|
1127
PUT
Boston Beer
SAM
$1.89B
| $41.2M | 0.01% |
135,900
+24,500
| +22% | +$8.52M |
|
1128
Valero Energy
VLO
$95.1B
| $41.1M | 0.01% |
386,870
+86,242
| +29% | +$10.2M |
|
1129
Kroger
KR
$34.3B
| $41.1M | 0.01% |
867,351
+242,097
| +39% | +$12.9M |
|
1130
PUT
Kohl's
KSS
$2.19B
| $41M | 0.01% |
1,147,600
+840,600
| +274% | +$41.2M |
|
1131
Liberty Global Class A
LBTYA
$3.55B
| $40.9M | 0.01% |
1,940,767
+531,330
| +38% | +$12.5M |
|
1132
West Pharmaceutical
WST
$24.8B
| $40.8M | 0.01% |
134,933
-260,198
| -66% | -$84.7M |
|
1133
Murphy USA
MUSA
$10.1B
| $40.8M | 0.01% |
175,203
+67,830
| +63% | +$16M |
|
1134
Honeywell
HON
$74.6B
| $40.7M | 0.01% |
248,719
-25,099
| -9% | -$4.51M |
|
1135
PUT
PPG Industries
PPG
$25.5B
| $40.7M | 0.01% |
356,200
+289,500
| +434% | +$36.2M |
|
1136
Penumbra
PEN
$12.9B
| $40.7M | 0.01% |
326,633
-40,516
| -11% | -$6.43M |
|
1137
PUT
Crown Castle
CCI
$31.5B
| $40.6M | 0.01% |
241,000
+76,100
| +46% | +$13.8M |
|
|
APGB
1138
DELISTED
Apollo Strategic Growth Capital II
APGB
| $40.4M | 0.01% |
4,114,391
+1,808
| +0% | +$17.7K |
|
1139
PUT
BILL Holdings
BILL
$4.85B
| $40.3M | 0.01% |
366,600
+46,100
| +14% | +$6.71M |
|
1140
PUT
Teladoc Health
TDOC
$1.26B
| $40.3M | 0.01% |
1,212,740
-820,168
| -40% | -$34.8M |
|
1141
Netflix
NFLX
$326B
| $40.3M | 0.01% |
2,302,700
-1,412,080
| -38% | -$31.3M |
|
1142
CALL
Sysco
SYY
$40.5B
| $40.2M | 0.01% |
475,100
-37,800
| -7% | -$3.17M |
|
|
AZEK
1143
DELISTED
The AZEK Co
AZEK
| $40.1M | 0.01% |
2,398,040
+571,674
| +31% | +$11.7M |
|
1144
Schrodinger
SDGR
$1.38B
| $40.1M | 0.01% |
1,519,434
+589,469
| +63% | +$15.8M |
|
1145
CALL
Universal Display
OLED
$4.23B
| $40.1M | 0.01% |
396,100
+192,000
| +94% | +$24.7M |
|
|
K
1146
PUT
DELISTED
Kellanova
K
| $40M | 0.01% |
597,678
+40,789
| +7% | +$2.65M |
|
|
FOLD
1147
DELISTED
Amicus Therapeutics
FOLD
| $40M | 0.01% |
3,727,540
+2,185,467
| +142% | +$18M |
|
1148
CALL
Agilent Technologies
A
$41.9B
| $40M | 0.01% |
336,900
+68,100
| +25% | +$8.37M |
|
1149
Vanguard Short-Term Bond ETF
BSV
$45.7B
| $40M | 0.01% |
520,733
-3,692,491
| -88% | -$284M |
|
1150
PUT
iShares Biotechnology ETF
IBB
$9.77B
| $40M | 0.01% |
339,800
-31,500
| -8% | -$3.74M |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.